- Home
- EXEL vs BWA Comparison
EXEL vs BWA Comparison
Compare EXEL & BWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | BWA |
|---|---|---|
| Founded | 1994 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 10.9B |
| IPO Year | 2000 | 1995 |
Fundamental Metrics
Financial Performance| Metric | EXEL | BWA |
|---|---|---|
| Price | $41.26 | $50.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 15 |
| Target Price | $46.45 | ★ $57.60 |
| AVG Volume (30 Days) | 2.8M | ★ 3.4M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 2.78 | 1.28 |
| Revenue | $452,477,000.00 | ★ $14,316,000,000.00 |
| Revenue This Year | $13.66 | $0.54 |
| Revenue Next Year | $13.73 | $4.85 |
| P/E Ratio | ★ $14.80 | $41.01 |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $32.38 | $24.40 |
| 52 Week High | $48.74 | $70.08 |
Technical Indicators
Market Signals| Indicator | EXEL | BWA |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 38.87 |
| Support Level | $40.01 | $41.46 |
| Resistance Level | $44.15 | $70.08 |
| Average True Range (ATR) | 1.33 | 1.74 |
| MACD | -0.16 | -0.95 |
| Stochastic Oscillator | 26.06 | 0.43 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About BWA BorgWarner Inc.
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2024, 23% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.